Sociodemographic and clinical characteristics of the sample at baseline
Variable | |
Gender, n (%) | |
Women | 74 (84) |
Men | 14 (16) |
Age, mean (SD) | |
Mean age | 32.5 (11.6) |
Min–max | 18–72 |
Married, n (%) | 14 (16) |
Highest education, n (%) | |
Primary school | 9 (10) |
High school | 51 (58) |
College/university | 26 (30) |
Doctorate | 2 (2) |
Occupational status | |
Working | 49 (56) |
Student | 22 (25) |
Retired | 3 (3) |
Unemployed | 13 (15) |
Disability pension | 1 (1) |
Insight, n (%) | |
Good | 46 (52) |
Poor | 34 (39) |
Delusional | 8 (9) |
BDD duration, mean (SD) | |
Mean length in years | 18.8 (13.3) |
Comorbidity, n (%) | |
Current depressive episode | 44 (50) |
Panic disorder | 3 (3) |
Social anxiety disorder | 25 (28) |
Generalised anxiety disorder | 15 (17) |
Bulimia nervosa | 2 (2) |
ADHD | 2 (2) |
Obsessive–compulsive disorder | 8 (9) |
Current medication, n (%) | |
SSRI | 12 (14) |
SNRI | 2 (2) |
Other antidepressants | 7 (8) |
Mood stabilisers | 4 (5) |
Benzodiazepines | 3 (3) |
Neuroleptics | 2 (2) |
Methylphenidate | 2 (2) |
Previous psychosocial treatment, n (%) | |
CBT for BDD | 10 (11) |
Psychosocial treatment for depression or anxiety | 53 (60) |
Plastic surgery, n (%) | |
Previous plastic surgery | 21 (24) |
Mean no. of surgeries (SD) | 2.3 (1.7) |
Min–max no. of surgeries | 1–6 |
ADHD, attention-deficit hyperactivity disorder; BDD, body dysmorphic disorder; CBT, cognitive–behavioural therapy; SNRI, serotonin–norepinephrine reuptake Inhibitors; SSRI, selective serotonin reuptake inhibitors.